Skip to main content
. 2022 Oct 31;6:e2200246. doi: 10.1200/PO.22.00246

FIG 1.

FIG 1.

Step-by-step approach for analyzing the number of patients with advanced non–small-cell lung cancer lost at each step of the precision oncology pathway. CNB, core-needle biopsies; ddPCR, droplet digital polymerase chain reaction; FISH, fluorescence in situ hybridization; FNA, fine-needle aspirates; IHC, immunohistochemistry; IO, immuno-oncology; aNSCLS, advanced non-small-cell lung cancer; NGS, next-generation sequencing; PD-L1, programmed death-ligand 1; RT-PCR, reverse transcriptase polymerase chain reaction; TKI, tyrosine kinase inhibitor.